Securities Class Actions Filed
Rosen Law Firm Announces Securities Class Actions Against Five Major Companies
Anonymous
Key Points
1
Rosen Law Firm identifies Phillip Kim, Esq. as the contact for investors in the Smartsheet, Unicycive, UWM Holdings, FuelCell Energy and ARS Pharmaceuticals actions; investors can reach him toll-free at 866-767-3653 or by email at case@rosenlegal.com.
2
The firm explains that a lead plaintiff is a representative party who acts on behalf of other class members and directs the litigation.
3
Rosen says it represents investors globally and focuses on securities class actions and shareholder derivative litigation, distinguishing its practice from firms that may merely refer cases to other counsel.
4
The firm touts its litigation record, saying it has recovered billions of dollars for investors, ranked among the top four firms for securities class-action settlements each year since 2013, and secured more than $438 million for investors in 2019 alone.
Rosen Law Firm has filed or announced securities class actions against five companies—Smartsheet, Unicycive Therapeutics, UWM Holdings, FuelCell Energy, and ARS Pharmaceuticals—targeting investors who bought shares during 2024 through 2026. Rosen says eligible investors can seek compensation with no upfront legal costs through contingency-fee representation. Lead-plaintiff deadlines range from October 5 to November 10, 2026, and investors interested in directing the litigation must act quickly.
A lead plaintiff acts as the class representative, selects counsel, and helps guide litigation strategy and settlement talks. Rosen represents investors globally and says it has recovered billions of dollars for investors, ranking among the top four firms for securities class-action settlements every year since 2013.
Five Companies Face Investor Lawsuits Over Alleged Misconduct
The cases span diverse industries: enterprise software, therapeutics development, mortgage lending, fuel-cell energy technology, and pharmaceuticals. Rosen says each lawsuit alleges that management made material misstatements or omissions about company performance, regulatory progress, or market conditions. Rosen notes that stock price declines alone do not qualify investors for compensation—purchases must fall within the company's designated class period.
Class periods differ for each company. Unicycive Therapeutics covers December 29, 2025 to June 29, 2026. UWM Holdings spans March 9 to August 5, 2026. Rosen emphasizes that eligibility hinges on purchase timing, transaction records, and proof of economic loss tied to the alleged corrective disclosure.
Understanding the Lead Plaintiff Role
A lead plaintiff is not a passive participant. Courts appoint the investor they deem most adequate to represent the class, weighing factors such as financial stake and claim typicality. The lead plaintiff then directs the legal strategy, selects counsel, and participates in settlement negotiations. Rosen says this role carries real power over how the case unfolds.
The October 5, October 13, November 2, and November 10 deadlines are strategic milestones for investors seeking the leadership role. Rosen explains that missing these deadlines typically bars investors from serving as lead plaintiff, though they may still participate in the class if a lawsuit succeeds. Investors interested in leading must contact Rosen or review case materials immediately.
How to Participate or Lead the Litigation
Investors can reach Rosen Law Firm toll-free at 866-767-3653 or email case@rosenlegal.com. Phillip Kim, Esq., handles all five actions—Smartsheet, Unicycive Therapeutics, UWM Holdings, FuelCell Energy, and ARS Pharmaceuticals. Rosen operates on a contingency-fee basis, meaning investors pay nothing unless the firm recovers money.
Rosen distinguishes itself from firms that merely refer cases elsewhere, saying it handles securities litigation and shareholder derivative disputes directly. The firm highlights its track record: more than $438 million recovered for investors in 2019 alone and consistent ranking among the top four firms for class-action settlements since 2013. Lawsuits have already been filed in each case; investors seeking to act should do so before their company's deadline passes.
Sentiment
Mostly NegativeNEGATIVENEUTRALPOSITIVE
Publishers
12
Articles
63
Reach
75
A
AnonymousAuthor
